Assessment of brain SPECT Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

Neurology

Volumn 46, Issue 1, 1996, Pages 278-285

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BRAIN INJURY; BRAIN PERFUSION; BRAIN SCINTISCANNING; COST; DIAGNOSTIC IMAGING; HUMAN; HUNTINGTON CHOREA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SAFETY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; SUBARACHNOID HEMORRHAGE; TRANSIENT ISCHEMIC ATTACK;

BRAIN; HUMANS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029976758     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.46.1.278     Document Type: Article

References (97)

1. Masdeu J, Brass L, Holman L, Kushner M. Brain single-photon emission computed tomography. Neurology 1994;44: 1970-1977.
2. Piez CW, Holman BL. Single photon emission computed tomography. Computed Radiol 1985;9:201-211.
3. English RJ, Brown SE. SPECT: single photon emission computed tomography; a primer, 2nd ed. New York: Society of Nuclear Medicine, 1990.
4. Kung HF. New technetium-99m-labeled brain perfusion imaging agents. Semin Nucl Med 1990;20:150-158.
5. Kuhl DE, Barrco JR, Huang SC, et al. Quantifying local cerebral blood flow N-isopropyl-p-I-123 iodoamphetamine (IMP) tomography. J Nucl Med 1982;23:196-203.
6. Neirinckx RD, Canning LR, Piper IM, et al. Technetium-99m d,1-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 1987;28:191-202.
7. Holman BL, Hellman RS, Goldsmith SJ, et al. Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction. J Nucl Med 1989;30:1018-1024.
8. Devous MD, Stokey EM, Bonte FJ. Quantitative imaging of regional cerebral blood flow by dynamic single-photon tomography. In: Holman BL, ed. Radionuclide imaging of the brain. New York: Churchill Livingstone, 1985:135-162.
9. Eckelman WC, Reba RC, Rzeszotarski EJ, et al. External imaging of cerebral muscarinic acetylcholine receptors. Science 1984;223:291-293.
10. De Roo M, Mortelmans L, Devos P, et al. Clinical experience with Tc-99m HM-PAO high resolution SPECT of the brain in patients with cerebrovascular accidents. Eur J Nucl Med 1989;15:9-15.
11. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989; 91:311-321.
12. Bose A, Pacia SV, Fayad P, Smith EO, Brass LM, Hoffer P. Cerebral blood flow (CBF) imaging compared to CT during the initial 24 hours of cerebral infarction. Neurology 1990; 40(suppl 1):190.
13. Podreka I, Suess E, Goldenberg G, et al. Initial experience with technetium-99m HM-PAO brain SPECT. J Nucl Med 1987;28:1657-1666.
14. Yeh SH, Liu RS, Hu HH, et al. Brain SPECT imaging with 99mTc-hexamethylpropyleneamine oxime in the early detection of cerebral infarction: comparison with transmission computed tomography. Nucl Med Commun 1986;7:873-878.
15. de Bruine JF, Limburg M, van Royen EA, Hijdra A, Hill TC, van der School JB. SPECT brain imaging with 201 diethyldithiocarbamate in acute ischaemic stroke. Eur J Nucl Med 1990;17:248-251.
16. Alberts MJ, Faulstich ME, Gray L. Stroke with negative brain magnetic resonance imaging. Stroke 1992;23:663-667.
17. Brass LM, Walovitch RC. Two prospective, blinded, controlled trials of Tc99m bicisate brain SPECT and standard neurological evaluation for identifying and localizing ischemic strokes. J Stroke Cerebrovasc Diseases 1992;1(suppl 1):S59.
18. Levy DE, Caronna JJ, Lapinski RH, Scherer PB, Pulsinelli WA, Plum F. Clinical predictors of recovery from ischemic stroke. In: Reivich M, Hurtig HI, eds. Cerebrovascular diseases. New York: Raven Press, 1983:121-128.
19. Tikofsky RS, Hellman RS. Brain single photon emission computed tomography: newer activation and intervention studies. Semin Nucl Med 1991;21:40-57.
20. Rango M, Candelise L, Perani D, et al. Cortical pathophysiology and clinical neurological abnormalities in acute cerebral ischemia. A serial study with single photon emission computed tomography. Arch Neurol 1989;46:1318-1322.
21. Vallar G, Perani D, Cappa SF, Messa C, Lenzi GL, Fazio F. Recovery from aphasia and neglect after subcortical stroke: neuropsychological and cerebral perfusion study. J Neurol Neurosurg Psychiatry 1988;51:1269-1276.
22. Raynaud C, Rancurel G, Samson Y, et al. Pathophysiologic study of chronic infarcts with I-123 isopropyl iodo-amphetamine (IMP): the importance of periinfarct area. Stroke 1987; 18:21-29.
23. Giubilei F, Lenzi GL, Di Piero V, et al. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. Stroke 1990;21:895-900.
24. Fayad PB, Hoffer PB, Brass LM. Prediction of outcome with early SPECT in acute cerebral infarction [abstract]. Ann Neurol 1990;26:227.
25. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 1988;19:547-554.
26. Bogousslavsky J, Regli F. Borderzone infarctions distal to internal carotid artery occlusion: prognostic implications. Ann Neurol 1986;20:346-350.
27. Schroeder T. Hemodynamic significance of internal carotid artery disease. Acta Neurol Scand 1988;77:353-372.
28. Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR. Determinants of early recurrence of cerebral infarction: the Stroke Data Bank. Stroke 1989;20:983-989.
29. Powers WJ, Tempel LW, Grubb RLJ. Influence of cerebral hemodynamics on stroke risk: one-year follow-up of 30 medically treated patients. Ann Neurol 1989;25:325-330.
30. Pacia SV, Bose A, Fayad P, Smith EO, Hoffer P, Brass LM. Single photon emission computed tomography (SPECT) in distal field infarction. Neurology 1990;41(Suppl 1):214.
31. Baird AE, Donna GA, Saling M. Mechanisms and clinical features of internal watershed infarction. Clin Exp Neurol 1991; 28:50-55.
32. 99mTc-bicisate in the localization and definition of mechanism of ischemic stroke. J Cereb Blood Flow Metab 1994;14:S91-98.
33. Hartmann A. Prolonged disturbances of regional cerebral blood flow in transient ischemic attacks. Stroke 1985;16:932-939.
34. Chollet F, Celsis P, Clanet M, Guiraud-Chaumeil B, Rascol A, Marc-Vergnes JP. SPECT study of cerebral blood flow reactivity after acetazolamide in patients with transient ischemic attacks. Stroke 1989;20:458-464.
35. Bogousslavsky J, Delaloye-Bischof A, Regli F, Delaloye B. Prolonged hypoperfusion and early stroke after transient ischemic attack. Stroke 1990;21:40-46.
36. Davis SM, Andrews JT, Lichtenstein M, Rossiter SC, Kaye AH, Hopper J. Correlations between cerebral arterial velocities, blood flow, and delayed ischemia after subarachnoid hemorrhage. Stroke 1992;23:492-497.
37. Batjer HH, Devous MD, Seibert GB, Purdy PD, Bonte FJ. Intracranial arteriovenous malformation: relationships between clinical factors and surgical complications. Neurosurgery 1989;24:75-79.
38. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989;71:342-346.
39. 99mTc-HMPAO. AJNR 1991;12:1187-1192.
40. 99mTc-HMPAO SPECT with CT and MRI studies. Nuklearmedizin 1990;29:252-258.
41. Masdeu JC, Yudd A, Van Heertum RL, et al. Single-photon emission computed tomography in human immunodeficiency virus encephalopathy: a preliminary report. J Nucl Med 1991; 32:1471-1475.
42. Abdel-Dayem HM, Sadek SA, Kouris K, et al. Changes in cerebral perfusion after acute head injury: comparison of CT with Tc-99m HM-PAO SPECT. Radiology 1987;165:221-226.
43. 123I). Nucl Med Commun 1990; 11:361-367.
44. Roper SN, Mena I, King WA, et al. An analysis of cerebral blood flow in acute closed-head injury using technetium-99m-HMPAO SPECT and computed tomography. J Nucl Med 1991; 32:1684-1687.
45. Ichise M, Chung DG, Wang P, Wortzman G, Gray BG, Franks W. Technetium-99m-HMPAO SPECT, CT and MRI in the evaluation of patients with chronic traumatic brain injury: a correlation with neuropsychological performance. J Nucl Med 1994;35:217-226.
46. Jacobs A, Put E, Ingels M, Bossuyt A. Prospective evaluation of technetium-99m-HMPAO SPECT in mild and moderate traumatic brain injury. J Nucl Med 1994;35:942-947.
47. Masdeu JC, Van Heertum R, Kleiman A, et al. Early SPECT in mild head trauma. A controlled study. J Neuroimag 1994;4: 177-181.
48. Gray BG, Ichise M, Chung D, Kirsh JC, Franks W. Technetium-99m-HMPAO SPECT in the evaluation of patients with a remote history of traumatic brain injury: a comparison with x-ray computed tomography. J Nucl Med 1992;33:52-58.
49. Anonymous. SPECT and PET in epilepsy [editorial]. Lancet 1989;1:135-137.
50. Cendes F, Andermann F, Gloor P, et al. MRI volumetric measurement of amygdala and hippocampus in temporal lobe epilepsy. Neurology 1993;43:719-725.
51. Kuzniecky R, Murro A, King D, et al. Magnetic resonance imaging in childhood intractable partial epilepsies: pathologic correlations. Neurology 1993;43:681-687.
52. Kuzniecky R, Mountz J, Wheatly G, Morawetz R. Ictal single-photon emission computed tomography demonstrates localized epileptogenesis in cortical dysplasia. Ann Neurol 1993;34: 627-631.
53. Palmini A, Andermann F, Olivier A, et al. Focal neuronal migration disorders and intractable partial epilepsy: a study of 30 patients. Ann Neurol 1991;30:741-749.
54. Devous MD, Leroy RF, Homan RW. Single-photon emission computed tomography in epilepsy. Sem Nucl Med 1990;20: 325-341.
55. Lee BI, Markand ON, Wellman HN, et al. HIPDM-SPECT in patients with medically intractable complex partial seizures. Arch Neurol 1988;45:397-402.
56. Rowe CC, Berkovic SF, Sia ST, et al. Localization of epileptic foci with postictal single photon emission computed tomography. Ann Neurol 1989;26:660-668.
57. Biersack HJ, Elger CE, Grundwald F, Reichmann K, Durwen HF. Brain in epilepsy. Adv Func Neuroimaging 1988;1:4-9.
58. 99mTc-HM-PAO in focal epilepsy. J Cereb Blood Flow Metab 1988;8:S95-S100.
59. Stefan H, Bauer J, Feistel H, et al. Regional cerebral blood flow during focal seizures of temporal and frontocentral onset. Ann Neurol 1990;27:162-166.
60. Shen W, Lee BI, Park HM, et al HIPDM-SPECT brain imaging in the presurgical evaluation of patients with intractable seizures. J Nuclear Med 1990;31:1280-1284.
61. Rowe CC, Berkovic SF, Austin MC, et al. Visual and quantitative analysis of interictal SPECT with technetium-99m-HMPAO in temporal lobe epilepsy. J Nucl Med 1991;32:1688-1694.
62. Markand ON, Spencer SS, Andersen AR. SPECT in epilepsy. J Neuroimaging 1995;5:523-533.
63. Marks DA, Katz A, Hoffer PB, Spencer SS. Localization of extratemporal epileptic foci during ictal single photon emission computed tomography. Ann Neurol 1992;31:250-255.
64. Katz A, Bose A, Lind SJ, Spencer SS. SPECT in patients with epilepsia partialis continua. Neurology 1990;40:1848-1850.
65. Lee BI, Markand ON, Wellman HN, et al. HIPDM single photon emission tomography brain imaging in partial onset secondarily generalized tonic-clonic seizures. Epilepsia 1987; 28:305-311.
66. Hart J, Lewis P, Lesser R, et al. Anatomic correlates of memory from intracarotid amobarbital injections with technetium-99m hexamethylpropyleneamine oxime SPECT. Arch Neurol 1993;50:745-752.
67. Andreasen NC. Brain imaging applications in psychiatry. Science 1988;239:1381-1388.
68. Cordes M, Henkes H, Ferstl F, et al. Evaluation of focal epilepsy: a SPECT scanning comparison of 123-I-iomazenil versus HM-PAO. AJNR 1992;13:249-253.
69. Hellman RS, Tikofsky RS, Collier BD, et al. Alzheimer's disease: quantitative analysis of I-123 iodoamphetamine SPECT brain imaging. Radiology 1989;172:183-188.
70. Johnson KA, Holman L, Rosen J, Nagel S, English RJ, Growdon JH. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease. Arch Int Med 1990;150:752-756.
71. Komatani A, Yamaguchi K, Sugai Y, et al. Assessment of demented patients by dynamic SPECT of inhaled xenon-133. J Nucl Med 1988;29:1621-1626.
72. Perani D, Di Piero V, Vallar G, et al. Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease. J Nucl Med 1988;29:1507-1514.
73. Montaldi D, Brooks DN, McColl JH, et al. Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1990;53: 33-38.
74. Besson JAO, Crawford JR, Parker DM, et al. Multimodal imaging in Alzheimer's disease. The relationship between MRI, SPECT, cognitive and pathologic changes. Br J Psychiatry 1990;157:216-220.
75. Bonte FJ, Tintner R, Weiner MF, Bigio EH, White C3. Brain blood flow in the dementias: SPECT with histopathologic correlation. Radiology 1993;186:361-365.
76. Geaney DP, Abou-saleh MT. The use and applications of single-photon emission computerised tomography in dementia. Br J Psychiatry 1990;157(suppl 9):66-75.
77. Jagust W, Reed B, Ellis W, Eberling J, Budinger T. Single-photon emission computed tomographic perfusion imaging in autopsy-diagnosed dementia. J Neuroimaging 1993;3:93-99.
78. Jobst KA, Smith AD, Barker CS, et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:190-194.
79. Bonte FJ, Ross ED, Chehabi HH, Devous MD. SPECT study of regional cerebral blood flow in Alzheimer's disease. J Comput Assist Tomogr 1986;10:579-583.
80. Holman BL, Johnson KA, Gerada B, Carvalho PA, Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT [published erratum appears in J Nucl Med 1992;33:484]. J Nucl Med 1992;33:181-185.
81. Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 1987;44:258-262.
82. Frlich L, Eilles C, Ihl R, Maurer K, Lanczik M. Stage-dependent reductions of regional cerebral blood flow measured by HMPAO-SPECT in dementia of Alzheimer type. Psychiatry Res 1989;29:347-350.
83. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
84. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114:797-811.
85. Reed BR, Jagust WJ, Seab JP, Ober BA. Memory and regional cerebral blood flow in mildly symptomatic Alzheimer's disease. Neurology 1989;39:1537-1539.
86. Holman BL, Nagel JS, Johnson KA, Hill TC. Imaging dementia with SPECT. Ann NY Acad Sci 1991;620:165-174.
87. Gemmell HG, Sharp PF, Smith FW, et al. Cerebral blood flow measured by SPECT as a diagnostic tool in the study of dementia. Psychiatry Res 1989;29:327-329.
88. Habert MO, Spampinato U, Mas JL, et al. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia. Eur J Nucl Med 1991;18: 3-11.
89. Nagel JS, Ichise M, Holman BL. The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans. Semin Nucl Med 1991;21:11-23.
90. Grunwald F, Zierz S, Broich K, Schumacher S, Bockisch A, Biersack HJ. HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). J Nucl Med 1990;31:1740-1742.
91. 123IQNB and single photon emission computed tomography. Arch Neurol 1991;48:169-176.
92. Bonte FJ, Devous MDS, Reisch JS, et al. The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single-photon emission computed tomography. Invest Radiol 1989;24:99-103.
93. Geaney D, Soper N, Shepstone B, et al. Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer's disease. Lancet 1990;335:1484-1487.
94. Reid IC, Besson JA, Best PV, Sharp PF, Gemmell HG, Smith FW. Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography. J Neurol Neurosurg Psychiatry 1988;51:1264-1268.
95. Leblhuber F, Brucker B, Reisecker F, et al. Single photon emission computed tomography in subjects at risk for Huntington's chorea. J Neurol 1990;237:496-498.
96. Oder W, Goldenberg G, Podreka I, Deecke L. HM-PAO-SPECT in persistent vegetative state after head injury: prognostic indicator of the likelihood of recovery? Intensive Care Med 1991;17:149-153.
97. Laurin NR, Driedger AA, Hurwitz GA, et al. Cerebral perfusion imaging with technetium-99m HM-PAO in brain death and severe central nervous system injury. J Nucl Med 1989; 30:1627-1635.